Stablepoint Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.61M Buy
29,950
+193
+0.6% +$45K 1.05% 24
2026
Q1
$7.27M Sell
29,757
-5,495
-16% -$1.28M 1.08% 26
2025
Q4
$7.3M Sell
35,252
-343
-1% -$67.8K 1.14% 21
2025
Q3
$6.6M Buy
35,595
+257
+0.7% +$44K 1.05% 26
2025
Q2
$5.4M Buy
35,338
+645
+2% +$99.1K 0.92% 34
2025
Q1
$5.75M Buy
34,693
+1,228
+4% +$192K 1.04% 29
2024
Q4
$4.84M Buy
33,465
+371
+1% +$57.5K 0.89% 34
2024
Q3
$5.36M Buy
33,094
+19
+0.1% +$3.03K 0.98% 35
2024
Q2
$5.24M Buy
33,075
+2,262
+7% +$336K 1.02% 29
2024
Q1
$4.87M Buy
30,813
+5,090
+20% +$810K 0.99% 35
2023
Q4
$4.03M Buy
+25,723
New +$3.94M 1.03% 37

Other funds holding JNJ

Stablepoint Partners's JNJ Position: Q2 2026 in Review

Stablepoint Partners increased its Johnson & Johnson (JNJ) stake by 0.65% in Q2 2026, buying an estimated $45K and bringing the position to 29,950 shares worth $7.61M. The position accounts for 1.05% of the portfolio, ranked #24.

Stablepoint Partners first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Stablepoint Partners held 29,950 shares of Johnson & Johnson worth $7.61M as of Q2 2026.
  • Stablepoint Partners bought 193 Johnson & Johnson shares in Q2 2026, an estimated $45K.
  • Johnson & Johnson made up 1.05% of Stablepoint Partners's portfolio in Q2 2026, its #24 holding.
  • Stablepoint Partners first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Stablepoint Partners's 13F filing for Q2 2026, filed 9 Jul 2026.